Search Results - Daniel J. Powell

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    Adoptive T-cell therapy for malignant disorders by Daniel J. Powell, Bruce L. Levine

    Published in Haematologica (2008-10-01)
    Get full text
    Article


  2. 2

    A Novel Approach for the Treatment of T Cell Malignancies: Targeting T Cell Receptor Vβ Families by Jie Wang, Katarzyna Urbanska, Prannda Sharma, Reza Nejati, Lauren Shaw, Megan S. Lim, Stephen J. Schuster, Daniel J. Powell Jr.

    Published in Vaccines (2020-10-01)
    Get full text
    Article


  3. 3

    Dichotomous impact of affinity on the function of T cell engaging bispecific antibodies by Jason Manro, Carmine Carpenito, Flora Huang, Mathilde Poussin, Arlene Sereno, Xiufeng Wu, Shanshan Cao, Andrew Glasebrook, Daniel J Powell Jr, Stephen J Demarest

    Published in Journal for ImmunoTherapy of Cancer (2021-07-01)
    Get full text
    Article


  4. 4

    Day-4 myeloid dendritic cells pulsed with whole tumor lysate are highly immunogenic and elicit potent anti-tumor responses. by Cheryl Lai-Lai Chiang, Andrea R Hagemann, Rachel Leskowitz, Rosemarie Mick, Thomas Garrabrant, Brian J Czerniecki, Lana E Kandalaft, Daniel J Powell, George Coukos

    Published in PLoS ONE (2011-01-01)
    Get full text
    Article


  5. 5

    PARP Theranostic Auger Emitters Are Cytotoxic in BRCA Mutant Ovarian Cancer and Viable Tumors from Ovarian Cancer Patients Enable Ex-Vivo Screening of Tumor Response by Aladdin Riad, Sarah B. Gitto, Hwan Lee, Harrison D. Winters, Paul M. Martorano, Chia-Ju Hsieh, Kuiying Xu, Dalia K. Omran, Daniel J. Powell, Robert H. Mach, Mehran Makvandi

    Published in Molecules (2020-12-01)
    Get full text
    Article


  6. 6

    CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapy by Alba Rodriguez-Garcia, Rachel C. Lynn, Mathilde Poussin, Monika A. Eiva, Lauren C. Shaw, Roddy S. O’Connor, Nicholas G. Minutolo, Victoria Casado-Medrano, Gonzalo Lopez, Takami Matsuyama, Daniel J. Powell

    Published in Nature Communications (2021-02-01)
    Get full text
    Article


  7. 7

    A T cell receptor specific for an HLA-A*03:01-restricted epitope in the endogenous retrovirus ERV-K-Env exhibits limited recognition of its cognate epitope by Erin E. Grundy, Lauren C. Shaw, Loretta Wang, Abigail V. Lee, James Castro Argueta, Daniel J. Powell, Mario Ostrowski, R. Brad Jones, C. Russell Y. Cruz, Heather Gordish-Dressman, Nicole P. Chappell, Catherine M. Bollard, Katherine B. Chiappinelli

    Published in Mobile DNA (2024-10-01)
    Get full text
    Article


  8. 8

    S256: HLA-E/NKG2A CHECKPOINT DRIVES MULTIPLE MYELOMA RESISTANCE TO CAR-NK THERAPY by Jessica Encinas, Almudena García-Ortiz, Elena Maroto-Martín, Eva Castellano, Raquel Oliva, Rafael Alonso Fernández, Maria Teresa Cedena Romero, Alejandra Leivas, Beatriz Martín-Antonio, Guillermo Suñe, Dean A. Lee, Daniel J. Powell, Jr., Paula Río, Joaquín Martinez-Lopez, Antonio Valeri

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  9. 9

    Signaling via a CD28/CD40 chimeric costimulatory antigen receptor (CoStAR™), targeting folate receptor alpha, enhances T cell activity and augments tumor reactivity of tumor infilt... by Milena Kalaitsidou, Owen R. Moon, Martina Sykorova, Leyuan Bao, Yun Qu, Sujita Sukumaran, Michael Valentine, Xingliang Zhou, Veethika Pandey, Kay Foos, Sergey Medvedev, Daniel J. Powell Jr, Akshata Udyavar, Eric Gschweng, Ruben Rodriguez, Mark E. Dudley, Robert E. Hawkins, Gray Kueberuwa, John S. Bridgeman

    Published in Frontiers in Immunology (2023-11-01)
    Get full text
    Article


  10. 10

    Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma by Mehran Makvandi, Minu Samanta, Paul Martorano, Hwan Lee, Sarah B. Gitto, Khushbu Patel, David Groff, Jennifer Pogoriler, Daniel Martinez, Aladdin Riad, Hannah Dabagian, Michael Zaleski, Tara Taghvaee, Kuiying Xu, Ji Youn Lee, Catherine Hou, Alvin Farrel, Vandana Batra, Sean D. Carlin, Daniel J. Powell, Robert H. Mach, Daniel A. Pryma, John M. Maris

    Published in Communications Biology (2022-11-01)
    Get full text
    Article


  11. 11

    Natural TCRs targeting KRASG12V display fine specificity and sensitivity to human solid tumors by Adham S. Bear, Rebecca B. Nadler, Mark H. O’Hara, Kelsey L. Stanton, Chong Xu, Robert J. Saporito, Andrew J. Rech, Miren L. Baroja, Tatiana Blanchard, Maxwell H. Elliott, Michael J. Ford, Richard Jones, Shivang Patel, Andrea Brennan, Zachary O’Neil, Daniel J. Powell Jr., Robert H. Vonderheide, Gerald P. Linette, Beatriz M. Carreno

    Published in The Journal of Clinical Investigation (2024-11-01)
    Get full text
    Article


  12. 12

    Author Correction: Personalized cancer vaccine strategy elicits polyfunctional T cells and demonstrates clinical benefits in ovarian cancer by Janos L. Tanyi, Cheryl L.-L. Chiang, Johanna Chiffelle, Anne-Christine Thierry, Petra Baumgartener, Florian Huber, Christine Goepfert, David Tarussio, Stephanie Tissot, Drew A. Torigian, Harvey L. Nisenbaum, Brian J. Stevenson, Hajer Fritah Guiren, Ritaparna Ahmed, Anne-Laure Huguenin-Bergenat, Emese Zsiros, Michal Bassani-Sternberg, Rosemarie Mick, Daniel J. Powell, George Coukos, Alexandre Harari, Lana E. Kandalaft

    Published in npj Vaccines (2021-05-01)
    Get full text
    Article


  13. 13

    Personalized cancer vaccine strategy elicits polyfunctional T cells and demonstrates clinical benefits in ovarian cancer by Janos L. Tanyi, Cheryl L.-L. Chiang, Johanna Chiffelle, Anne-Christine Thierry, Petra Baumgartener, Florian Huber, Christine Goepfert, David Tarussio, Stephanie Tissot, Drew A. Torigian, Harvey L. Nisenbaum, Brian J. Stevenson, Hajer Fritah Guiren, Ritaparna Ahmed, Anne-Laure Huguenin-Bergenat, Emese Zsiros, Michal Bassani-Sternberg, Rosemarie Mick, Daniel J. Powell, George Coukos, Alexandre Harari, Lana E. Kandalaft

    Published in npj Vaccines (2021-03-01)
    Get full text
    Article


  14. 14

    NRCAM variant defined by microexon skipping is a targetable cell surface proteoform in high-grade gliomas by Priyanka Sehgal, Ammar S. Naqvi, Makenna Higgins, Jiageng Liu, Kyra Harvey, Julien Jarroux, Taewoo Kim, Berk Mankaliye, Pamela Mishra, Grace Watterson, Justyn Fine, Jacinta Davis, Katharina E. Hayer, Annette Castro, Adanna Mogbo, Charles Drummer, 4th, Daniel Martinez, Mateusz P. Koptyra, Zhiwei Ang, Kai Wang, Alvin Farrel, Mathieu Quesnel-Vallieres, Yoseph Barash, Jamie B. Spangler, Jo Lynne Rokita, Adam C. Resnick, Hagen U. Tilgner, Thomas De Raedt, Daniel J. Powell, Jr., Andrei Thomas-Tikhonenko

    Published in Cell Reports (2025-08-01)
    Get full text
    Article


Search Tools: